News Release

Gene mutations predict early, severe form of kidney disease

Genetic testing could identify children at risk

Peer-Reviewed Publication

American Society of Nephrology

Washington, DC (Monday, October 24, 2011) — The most common kidney disease passed down through families, autosomal dominant polycystic kidney disease (ADPKD) affects one in 400 to 1,000 individuals and is characterized by cysts on the kidneys. The condition slowly gets worse and leads to kidney failure.

Most ADPKD cases arise in adults, but some patients show severe symptoms of the disease in early childhood. New research indicates that these severely affected patients carry, in addition to expected inherited genetic defects, further mutations that aggravate the disease.The study, conducted by Carsten Bergmann, MD (Bioscientia Center for Human Genetics Ingelheim and RWTH Aachen University, in Germany) and his colleagues appears in an upcoming issue of the Journal of the American Society Nephrology (JASN), a publication of the American Society of Nephrology..

The researchers studied eight pedigrees in which the severely affected patients were the only family members who had gene mutations other than those that are known to cause ADPKD.

The analysis revealed that additional mutations worsen the disease and contribute to early and severe symptoms.

"Our findings are crucial for understanding polycystic kidney disease, and they help explain why one family member might be profoundly affected while another one only shows mild clinical features," said Dr. Bergmann. He added that similar events may occur in other diseases that range in severity.

The results may help clinicians as they provide genetic counseling for ADPKD patients, as few know that their future children could develop an early, severe form of the disease. The findings might also help investigators design new therapies for ADPKD.

###

Study co-authors include Jennifer von Bothmer, Nadina Bruchle, Andreas Venghaus, Valeska Frank, PhD, Henry Fehrenbach, MD, Tobias Hampel, MD, Lars Pape, MD, Annegret Buske, MD, Jon Jonsson, MD, PhD, Nanette Sarioglu, MD, Antónia Santos, MD, Jose Ferreira, MD, Jan Becker, MD, Reinhold Cremer, MD, Julia Hoefele, MD, Marcus R. Benz, MD, Lutz Weber, MD, Reinhard Buettner, MD, and Klaus Zerres, MD.

Disclosures: Carsten Bergmann and Valeska Frank are employees of Bioscientia, Center for Human Genetics in Ingelheim, Germany. The study was supported by the German Research Fund (DFG), the German Kidney Foundation, and the PKD Foundation.

The article, entitled "Mutations in Multiple PKD Genes May Explain Early and Severe Polycystic Kidney Disease," will appear online at http://jasn.asnjournals.org/ on Monday, October 24, 2011, doi: 10.1681/ASN.2010101080.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 12,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.